Response to mRNA vaccination for COVID-19 among patients with multiple myeloma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Response to mRNA vaccination for COVID-19 among patients with multiple myeloma
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-30
DOI
10.1038/s41375-021-01354-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
- (2021) Florian Krammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
- (2021) Pengfei Wang et al. Cell Host & Microbe
- Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
- (2021) Sarah Bird et al. Lancet Haematology
- COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care Professionals
- (2021) A.M. Shields et al. JOURNAL OF DENTAL RESEARCH
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET ONCOLOGY
- Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
- (2020) Heinz Ludwig et al. LEUKEMIA
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization
- (2020) Eric Salazar et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations
- (2019) Corrado Girmenia et al. BLOOD REVIEWS
- Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study
- (2018) Rasmus Sørrig et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial
- (2015) David Rey et al. LANCET INFECTIOUS DISEASES
- Changing treatment paradigms for patients with plasma cell myeloma: Impact upon immune determinants of infection
- (2014) Benjamin W. Teh et al. BLOOD REVIEWS
- Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
- (2014) C. Blimark et al. HAEMATOLOGICA
- Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma
- (2014) E Kastritis et al. LEUKEMIA
- Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
- (2013) Younghun Jung et al. Nature Communications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started